Overview

Second Study of the Effect of Teriparatide on Hip Fracture Healing

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether teriparatide, given for 6 months versus placebo, will improve the healing of hip (femoral neck) fractures that are repaired during surgery using certain types of orthopedic screws. The study will enroll men and postmenopausal women at least 50 years of age with a recent hip (femoral neck) fracture caused by low-trauma (for example, fall from standing height or less).
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Calcium
Teriparatide
Vitamin D